Where plaintiffs showed that their federal and state antitrust claims against Johnson & Johnson satisfied all of the ...

India's nuclear energy contribution is only 3% of its energy demand, far below France's 67%. A parliamentary panel highlighted project delays, insufficient funding for research at BARC, and financial ...

The U.S. Supreme Court on Monday denied certiorari to MSN Pharmaceuticals, Inc. v. Novartis Pharmaceuticals Corp., a case ...

The order followed the company’s assurance that it would not market any anti-obesity products in India until the patent ...

The court, however, permitted Sun Pharma to manufacture and export semaglutide to non-patent countries, extending the same relief it granted Dr. Reddy’s Laboratories in a similar dispute earlier this ...

By the end of 2025, the next round of opioid money from the lawsuit won by the West Virginia First Foundation will be ...

LONDON, Dec 11 (Reuters) - Hospitals in Britain are facing a "worst case scenario" from a wave of super flu, healthcare ...

Lawyer and human rights advocate Lorenzo “Erin” Tañada III welcomed the Professional Regulatory Commission (PRC) Board of ...

In a closely watched case, the U.S. solicitor general has urged the Supreme Court to review a controversy over so-called ...

A proposed combination of Johnson & Johnson’s multiple myeloma bispecific Tecvayli has turned up positive trial data that ...

Earlier, the court had declined Novo’s plea for an interim injunction against Dr Reddy’s Labs and permitted the company to ...

The US Supreme Court declined to consider a petition from MSN Pharmaceuticals Inc. challenging the validity of a patent covering Novartis Pharmaceuticals Corp.‘s blockbuster drug Entresto.